Search results

Clinical trials in Chinese T1D and T2D subjects were supportedby the China Jinan 5150 Program. Spanish clinical trial was sup-ported by the grants from the European Union FEDER funds,Principado de Asturias and FICYT (GRUPIN 14–069) ; Zhao, Y., Jiang, Z., Delgado, E., Li, H., Zhou, H., Hu, W., Perez-Basterrechea, M., Janostakova, A., Tan, Q., Wang, J., Mao, M., Yin, Z., Zhang, Y., Li, Y., Li, Q., Zhou, J., Li, Y., Revuelta, E.M., García-Gala, J.M., Wang, H., Perez-Lopez, S., Alvarez-Viejo, M., Menendez, E., Moss, T., Guindi, E., Otero, J.

This work was financially supported by: The Plan Nacional de I+D+I co-funding FEDER (PI18/01527); the Government of the Principality of Asturias PCTI-Plan de Ciencia, Tecnología e Innovación de Asturias co-funding 2018-2022/FEDER (IDI/2018/146); AECC (PROYE18061FERN); FGCSIC (0348_CIE_6_E); the Spanish Society of Diabetes (Programme/Funding for Young Researchers to JLFM), and IUOPA-ISPA-FINBA (the IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain); A.F.F is supported by a Miguel Servet II fellowship (contract CPII16/00007); R.F.P. is supported by the Severo Ochoa programme (BP17-114, Government of the Principality of Asturias).

Clinical trial was supported by the grants from the Instituto de Salud Carlos III (PI12/02587), Red de Investigación Renal (REDiNREN RD12/0021/0021), European Union FEDER funds, Principado de Asturias (Plan de Ciencia, Tecnologia e Innovacion), FICYT (GRUPIN 14-069), and Hackensack University Medical Center Foundation ; Delgado, E., Perez-Basterrechea, M., Suarez-Alvarez, B., Zhou, H., Revuelta, E.M., Garcia-Gala, J.M., Perez, S., Alvarez-Viejo, M., Menendez, E., Lopez-Larrea, C., Tang, R., Zhu, Z., Hu, W., Moss, T., Guindi, E., Otero, J., Zhao, Y.